ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Parasiticide for Animal Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-19P17468
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Parasiticide for Animal Market Research Report 2024
BUY CHAPTERS

Global Parasiticide for Animal Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-19P17468
Report
October 2025
Pages:142
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Eli Lilly
Ceva Sante Animlae
Virbac SA
Novartis
Merck
Boehringer Ingelheim
Vetoquinol
Zoetis Inc

Parasiticide for Animal Market

The global Parasiticide for Animal market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Parasiticides are medications used to treat and prevent parasitic infections in animals. These infections can be caused by various parasites such as worms (helminths), insects (ectoparasites), and fungi. Parasiticides are essential for maintaining the health and well-being of pets and livestock, as well as for controlling zoonotic diseases that can be transmitted to humans.
From a downstream perspective, Food-producing Animals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Parasiticide for Animal leading manufacturers including Bayer AG, Eli Lilly, Ceva Sante Animlae, Virbac SA, Novartis AG, Merck & Co., Boehringer Ingelheim, Vetoquinol., Zoetis, etc., dominate supply; the top five capture approximately % of global revenue, with Bayer AG leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Parasiticide for Animal market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Parasiticide for Animal Market Report

Report Metric Details
Report Name Parasiticide for Animal Market
Segment by Type
Segment by Application
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer AG, Eli Lilly, Ceva Sante Animlae, Virbac SA, Novartis AG, Merck & Co., Boehringer Ingelheim, Vetoquinol., Zoetis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Parasiticide for Animal study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Parasiticide for Animal Market report?

Ans: The main players in the Parasiticide for Animal Market are Bayer AG, Eli Lilly, Ceva Sante Animlae, Virbac SA, Novartis AG, Merck & Co., Boehringer Ingelheim, Vetoquinol., Zoetis

What are the Application segmentation covered in the Parasiticide for Animal Market report?

Ans: The Applications covered in the Parasiticide for Animal Market report are Food-producing Animals, Companion Animals

What are the Type segmentation covered in the Parasiticide for Animal Market report?

Ans: The Types covered in the Parasiticide for Animal Market report are Ectoparasiticides, Endoparasiticides

Recommended Reports

Animal Parasite Control

Companion Animal Care

Livestock Parasiticides

1 Study Coverage
1.1 Introduction to Parasiticide for Animal: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Parasiticide for Animal Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Ectoparasiticides
1.2.3 Endoparasiticides
1.3 Market Segmentation by Application
1.3.1 Global Parasiticide for Animal Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Food-producing Animals
1.3.3 Companion Animals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Parasiticide for Animal Revenue Estimates and Forecasts 2020-2031
2.2 Global Parasiticide for Animal Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Parasiticide for Animal Sales Estimates and Forecasts 2020-2031
2.4 Global Parasiticide for Animal Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Parasiticide for Animal Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Parasiticide for Animal Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Ectoparasiticides Market Size by Manufacturers
3.5.2 Endoparasiticides Market Size by Manufacturers
3.6 Global Parasiticide for Animal Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Parasiticide for Animal Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Parasiticide for Animal Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Parasiticide for Animal Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Parasiticide for Animal Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Parasiticide for Animal Sales and Revenue by Type (2020-2031)
6.4 North America Parasiticide for Animal Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Parasiticide for Animal Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Parasiticide for Animal Sales and Revenue by Type (2020-2031)
7.4 Europe Parasiticide for Animal Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Parasiticide for Animal Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Parasiticide for Animal Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Parasiticide for Animal Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Parasiticide for Animal Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Parasiticide for Animal Sales and Revenue by Type (2020-2031)
9.4 Central and South America Parasiticide for Animal Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Parasiticide for Animal Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Parasiticide for Animal Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Parasiticide for Animal Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Parasiticide for Animal Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Parasiticide for Animal Product Models, Descriptions and Specifications
11.1.4 Bayer AG Parasiticide for Animal Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Bayer AG Parasiticide for Animal Sales by Product in 2024
11.1.6 Bayer AG Parasiticide for Animal Sales by Application in 2024
11.1.7 Bayer AG Parasiticide for Animal Sales by Geographic Area in 2024
11.1.8 Bayer AG Parasiticide for Animal SWOT Analysis
11.1.9 Bayer AG Recent Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Corporation Information
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Parasiticide for Animal Product Models, Descriptions and Specifications
11.2.4 Eli Lilly Parasiticide for Animal Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Eli Lilly Parasiticide for Animal Sales by Product in 2024
11.2.6 Eli Lilly Parasiticide for Animal Sales by Application in 2024
11.2.7 Eli Lilly Parasiticide for Animal Sales by Geographic Area in 2024
11.2.8 Eli Lilly Parasiticide for Animal SWOT Analysis
11.2.9 Eli Lilly Recent Developments
11.3 Ceva Sante Animlae
11.3.1 Ceva Sante Animlae Corporation Information
11.3.2 Ceva Sante Animlae Business Overview
11.3.3 Ceva Sante Animlae Parasiticide for Animal Product Models, Descriptions and Specifications
11.3.4 Ceva Sante Animlae Parasiticide for Animal Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Ceva Sante Animlae Parasiticide for Animal Sales by Product in 2024
11.3.6 Ceva Sante Animlae Parasiticide for Animal Sales by Application in 2024
11.3.7 Ceva Sante Animlae Parasiticide for Animal Sales by Geographic Area in 2024
11.3.8 Ceva Sante Animlae Parasiticide for Animal SWOT Analysis
11.3.9 Ceva Sante Animlae Recent Developments
11.4 Virbac SA
11.4.1 Virbac SA Corporation Information
11.4.2 Virbac SA Business Overview
11.4.3 Virbac SA Parasiticide for Animal Product Models, Descriptions and Specifications
11.4.4 Virbac SA Parasiticide for Animal Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Virbac SA Parasiticide for Animal Sales by Product in 2024
11.4.6 Virbac SA Parasiticide for Animal Sales by Application in 2024
11.4.7 Virbac SA Parasiticide for Animal Sales by Geographic Area in 2024
11.4.8 Virbac SA Parasiticide for Animal SWOT Analysis
11.4.9 Virbac SA Recent Developments
11.5 Novartis AG
11.5.1 Novartis AG Corporation Information
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Parasiticide for Animal Product Models, Descriptions and Specifications
11.5.4 Novartis AG Parasiticide for Animal Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Novartis AG Parasiticide for Animal Sales by Product in 2024
11.5.6 Novartis AG Parasiticide for Animal Sales by Application in 2024
11.5.7 Novartis AG Parasiticide for Animal Sales by Geographic Area in 2024
11.5.8 Novartis AG Parasiticide for Animal SWOT Analysis
11.5.9 Novartis AG Recent Developments
11.6 Merck & Co.
11.6.1 Merck & Co. Corporation Information
11.6.2 Merck & Co. Business Overview
11.6.3 Merck & Co. Parasiticide for Animal Product Models, Descriptions and Specifications
11.6.4 Merck & Co. Parasiticide for Animal Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Merck & Co. Recent Developments
11.7 Boehringer Ingelheim
11.7.1 Boehringer Ingelheim Corporation Information
11.7.2 Boehringer Ingelheim Business Overview
11.7.3 Boehringer Ingelheim Parasiticide for Animal Product Models, Descriptions and Specifications
11.7.4 Boehringer Ingelheim Parasiticide for Animal Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Boehringer Ingelheim Recent Developments
11.8 Vetoquinol.
11.8.1 Vetoquinol. Corporation Information
11.8.2 Vetoquinol. Business Overview
11.8.3 Vetoquinol. Parasiticide for Animal Product Models, Descriptions and Specifications
11.8.4 Vetoquinol. Parasiticide for Animal Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Vetoquinol. Recent Developments
11.9 Zoetis
11.9.1 Zoetis Corporation Information
11.9.2 Zoetis Business Overview
11.9.3 Zoetis Parasiticide for Animal Product Models, Descriptions and Specifications
11.9.4 Zoetis Parasiticide for Animal Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Zoetis Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Parasiticide for Animal Industry Chain
12.2 Parasiticide for Animal Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Parasiticide for Animal Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Parasiticide for Animal Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Parasiticide for Animal Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Parasiticide for Animal Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Bayer
Eli Lilly
Ceva Sante Animlae
Virbac SA
Novartis
Merck
Boehringer Ingelheim
Vetoquinol
Zoetis Inc
List of Tables
 Table 1. Global Parasiticide for Animal Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Parasiticide for Animal Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Parasiticide for Animal Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Parasiticide for Animal Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Parasiticide for Animal Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Parasiticide for Animal Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Dose)
 Table 7. Global Parasiticide for Animal Sales by Region (2020-2025) & (K Dose)
 Table 8. Global Parasiticide for Animal Sales by Region (2026-2031) & (K Dose)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Parasiticide for Animal Sales by Manufacturers (2020-2025) & (K Dose)
 Table 11. Global Parasiticide for Animal Sales Share by Manufacturers (2020-2025)
 Table 12. Global Parasiticide for Animal Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Parasiticide for Animal Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Parasiticide for Animal by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parasiticide for Animal as of 2024)
 Table 16. Global Parasiticide for Animal Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Parasiticide for Animal Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Dose)
 Table 18. Key Manufacturers Parasiticide for Animal Manufacturing Base and Headquarters
 Table 19. Global Parasiticide for Animal Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Parasiticide for Animal Sales by Type (2020-2025) & (K Dose)
 Table 23. Global Parasiticide for Animal Sales by Type (2026-2031) & (K Dose)
 Table 24. Global Parasiticide for Animal Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Parasiticide for Animal Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Parasiticide for Animal ASP by Type (2020-2031) & (US$/Dose)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Parasiticide for Animal Sales by Application (2020-2025) & (K Dose)
 Table 29. Global Parasiticide for Animal Sales by Application (2026-2031) & (K Dose)
 Table 30. Parasiticide for Animal High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Parasiticide for Animal Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Parasiticide for Animal Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Parasiticide for Animal ASP by Application (2020-2031) & (US$/Dose)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Parasiticide for Animal Growth Accelerators and Market Barriers
 Table 37. North America Parasiticide for Animal Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Parasiticide for Animal Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Parasiticide for Animal Growth Accelerators and Market Barriers
 Table 40. Europe Parasiticide for Animal Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Parasiticide for Animal Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Parasiticide for Animal Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Parasiticide for Animal Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Parasiticide for Animal Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Parasiticide for Animal Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Parasiticide for Animal Investment Opportunities and Key Challenges
 Table 47. Central and South America Parasiticide for Animal Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Parasiticide for Animal Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Parasiticide for Animal Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Bayer AG Corporation Information
 Table 51. Bayer AG Description and Major Businesses
 Table 52. Bayer AG Product Models, Descriptions and Specifications
 Table 53. Bayer AG Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 54. Bayer AG Sales Value Proportion by Product in 2024
 Table 55. Bayer AG Sales Value Proportion by Application in 2024
 Table 56. Bayer AG Sales Value Proportion by Geographic Area in 2024
 Table 57. Bayer AG Parasiticide for Animal SWOT Analysis
 Table 58. Bayer AG Recent Developments
 Table 59. Eli Lilly Corporation Information
 Table 60. Eli Lilly Description and Major Businesses
 Table 61. Eli Lilly Product Models, Descriptions and Specifications
 Table 62. Eli Lilly Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 63. Eli Lilly Sales Value Proportion by Product in 2024
 Table 64. Eli Lilly Sales Value Proportion by Application in 2024
 Table 65. Eli Lilly Sales Value Proportion by Geographic Area in 2024
 Table 66. Eli Lilly Parasiticide for Animal SWOT Analysis
 Table 67. Eli Lilly Recent Developments
 Table 68. Ceva Sante Animlae Corporation Information
 Table 69. Ceva Sante Animlae Description and Major Businesses
 Table 70. Ceva Sante Animlae Product Models, Descriptions and Specifications
 Table 71. Ceva Sante Animlae Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 72. Ceva Sante Animlae Sales Value Proportion by Product in 2024
 Table 73. Ceva Sante Animlae Sales Value Proportion by Application in 2024
 Table 74. Ceva Sante Animlae Sales Value Proportion by Geographic Area in 2024
 Table 75. Ceva Sante Animlae Parasiticide for Animal SWOT Analysis
 Table 76. Ceva Sante Animlae Recent Developments
 Table 77. Virbac SA Corporation Information
 Table 78. Virbac SA Description and Major Businesses
 Table 79. Virbac SA Product Models, Descriptions and Specifications
 Table 80. Virbac SA Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 81. Virbac SA Sales Value Proportion by Product in 2024
 Table 82. Virbac SA Sales Value Proportion by Application in 2024
 Table 83. Virbac SA Sales Value Proportion by Geographic Area in 2024
 Table 84. Virbac SA Parasiticide for Animal SWOT Analysis
 Table 85. Virbac SA Recent Developments
 Table 86. Novartis AG Corporation Information
 Table 87. Novartis AG Description and Major Businesses
 Table 88. Novartis AG Product Models, Descriptions and Specifications
 Table 89. Novartis AG Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 90. Novartis AG Sales Value Proportion by Product in 2024
 Table 91. Novartis AG Sales Value Proportion by Application in 2024
 Table 92. Novartis AG Sales Value Proportion by Geographic Area in 2024
 Table 93. Novartis AG Parasiticide for Animal SWOT Analysis
 Table 94. Novartis AG Recent Developments
 Table 95. Merck & Co. Corporation Information
 Table 96. Merck & Co. Description and Major Businesses
 Table 97. Merck & Co. Product Models, Descriptions and Specifications
 Table 98. Merck & Co. Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 99. Merck & Co. Recent Developments
 Table 100. Boehringer Ingelheim Corporation Information
 Table 101. Boehringer Ingelheim Description and Major Businesses
 Table 102. Boehringer Ingelheim Product Models, Descriptions and Specifications
 Table 103. Boehringer Ingelheim Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 104. Boehringer Ingelheim Recent Developments
 Table 105. Vetoquinol. Corporation Information
 Table 106. Vetoquinol. Description and Major Businesses
 Table 107. Vetoquinol. Product Models, Descriptions and Specifications
 Table 108. Vetoquinol. Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 109. Vetoquinol. Recent Developments
 Table 110. Zoetis Corporation Information
 Table 111. Zoetis Description and Major Businesses
 Table 112. Zoetis Product Models, Descriptions and Specifications
 Table 113. Zoetis Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 114. Zoetis Recent Developments
 Table 115. Key Raw Materials Distribution
 Table 116. Raw Materials Key Suppliers
 Table 117. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 118. Milestones in Production Technology Evolution
 Table 119. Distributors List
 Table 120. Market Trends and Market Evolution
 Table 121. Market Drivers and Opportunities
 Table 122. Market Challenges, Risks, and Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources


List of Figures
 Figure 1. Parasiticide for Animal Product Picture
 Figure 2. Global Parasiticide for Animal Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Ectoparasiticides Product Picture
 Figure 4. Endoparasiticides Product Picture
 Figure 5. Global Parasiticide for Animal Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Food-producing Animals
 Figure 7. Companion Animals
 Figure 8. Parasiticide for Animal Report Years Considered
 Figure 9. Global Parasiticide for Animal Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Parasiticide for Animal Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Parasiticide for Animal Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Parasiticide for Animal Revenue Market Share by Region (2020-2031)
 Figure 13. Global Parasiticide for Animal Sales (2020-2031) & (K Dose)
 Figure 14. Global Parasiticide for Animal Sales (CAGR) by Region (2020-2031) (K Dose)
 Figure 15. Global Parasiticide for Animal Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Parasiticide for Animal Sales Volume Market Share in 2024
 Figure 17. Global Parasiticide for Animal Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Ectoparasiticides Revenue Market Share by Manufacturer in 2024
 Figure 20. Endoparasiticides Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Parasiticide for Animal Sales Market Share by Type (2020-2031)
 Figure 22. Global Parasiticide for Animal Revenue Market Share by Type (2020-2031)
 Figure 23. Global Parasiticide for Animal Sales Market Share by Application (2020-2031)
 Figure 24. Global Parasiticide for Animal Revenue Market Share by Application (2020-2031)
 Figure 25. North America Parasiticide for Animal Sales YoY (2020-2031) & (K Dose)
 Figure 26. North America Parasiticide for Animal Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Parasiticide for Animal Sales Revenue (US$ Million) in 2024
 Figure 28. North America Parasiticide for Animal Sales Volume (K Dose) by Type (2020- 2031)
 Figure 29. North America Parasiticide for Animal Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Parasiticide for Animal Sales Volume (K Dose) by Application (2020-2031)
 Figure 31. North America Parasiticide for Animal Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Parasiticide for Animal Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Parasiticide for Animal Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Parasiticide for Animal Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Parasiticide for Animal Sales YoY (2020-2031) & (K Dose)
 Figure 36. Europe Parasiticide for Animal Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Parasiticide for Animal Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Parasiticide for Animal Sales Volume (K Dose) by Type (2020-2031)
 Figure 39. Europe Parasiticide for Animal Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Parasiticide for Animal Sales Volume (K Dose) by Application (2020-2031)
 Figure 41. Europe Parasiticide for Animal Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Parasiticide for Animal Revenue (2020-2031) & (US$ Million)
 Figure 43. France Parasiticide for Animal Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Parasiticide for Animal Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Parasiticide for Animal Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Parasiticide for Animal Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Parasiticide for Animal Sales YoY (2020-2031) & (K Dose)
 Figure 48. Asia-Pacific Parasiticide for Animal Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Parasiticide for Animal Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Parasiticide for Animal Sales Volume (K Dose) by Type (2020- 2031)
 Figure 51. Asia-Pacific Parasiticide for Animal Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Parasiticide for Animal Sales Volume (K Dose) by Application (2020-2031)
 Figure 53. Asia-Pacific Parasiticide for Animal Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Parasiticide for Animal Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Parasiticide for Animal Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Parasiticide for Animal Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Parasiticide for Animal Revenue (2020-2031) & (US$ Million)
 Figure 58. India Parasiticide for Animal Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Parasiticide for Animal Sales YoY (2020-2031) & (K Dose)
 Figure 60. Central and South America Parasiticide for Animal Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Parasiticide for Animal Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Parasiticide for Animal Sales Volume (K Dose) by Type (2021-2031)
 Figure 63. Central and South America Parasiticide for Animal Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Parasiticide for Animal Sales Volume (K Dose) by Application (2020-2031)
 Figure 65. Central and South America Parasiticide for Animal Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Parasiticide for Animal Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Parasiticide for Animal Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Parasiticide for Animal Sales YoY (2020-2031) & (K Dose)
 Figure 69. Middle East and Africa Parasiticide for Animal Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Parasiticide for Animal Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Parasiticide for Animal Sales Volume (K Dose) by Type (2021-2031)
 Figure 72. South America Parasiticide for Animal Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Parasiticide for Animal Sales Volume (K Dose) by Application (2020-2031)
 Figure 74. Middle East and Africa Parasiticide for Animal Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Parasiticide for Animal Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Parasiticide for Animal Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Parasiticide for Animal Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Parasiticide for Animal Revenue (2020-2025) & (US$ Million)
 Figure 79. Parasiticide for Animal Industry Chain Mapping
 Figure 80. Regional Parasiticide for Animal Manufacturing Base Distribution (%)
 Figure 81. Global Parasiticide for Animal Production Market Share by Region (2020-2031)
 Figure 82. Parasiticide for Animal Production Process
 Figure 83. Regional Parasiticide for Animal Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Livestock Animal Parasiticides Market Insights Forecast to 2030
Global Companion Animal Parasiticides Market Insights Forecast to 2030
Animal Parasiticide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Parasiticides for Pets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pets Parasiticide Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Internal Parasiticide Market Insights Forecast to 2030
Global Pets External Parasiticide Market Insights Forecast to 2030
Global Pets Internal Parasiticide Market Insights Forecast to 2030
Global Livestock Internal Parasiticide Market Insights Forecast to 2030
Global Farm Animal Internal Parasiticide Market Insights Forecast to 2030
Global Animal External Parasiticide Market Insights Forecast to 2030
Global Farm Animal External Parasiticide Market Insights Forecast to 2030
Global Companion Animal Internal Parasiticide Market Insights Forecast to 2030
Global Livestock External Parasiticide Market Insights Forecast to 2030
Poultry Parasiticides and Disinfectants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Topical Animal Parasiticides Market Research Report 2024
Global Companion Animal External Parasiticide Market Insights Forecast to 2030
Animal Used Parasiticides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Companion Animal Anthelmintics Market Research Report 2024
Global Companion Animal Parasite Control Market Research Report 2024

RELATED REPORTS

Global Feline Infectious Peritonitis (FIP) Antivirals Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4U20267
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Global Anticoccidial Solutions Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-16R16865
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Bacterial Enteric Disease Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-3F17301
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Whooping Cough Vaccination Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-4B20221
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions